KCNQ channel openers (Jiangsu Simcere Pharmaceutical)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameKCNQ channel openers (Jiangsu Simcere Pharmaceutical)
Drug Alias Namesubstituted piperidine derivatives (Jiangsu Simcere Pharmaceutical)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionKCNQ (Kv7) potassium channel agonists
TargetsKCNQ (Kv7) potassium channel
Therapy Area/IndicationsEpilepsy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesJiangsu Simcere Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesJiangsu Simcere Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsEpilepsy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A